222 related articles for article (PubMed ID: 21342224)
1. Hypersensitivity syndrome due to trichloroethylene exposure: a severe generalized skin reaction resembling drug-induced hypersensitivity syndrome.
Watanabe H
J Dermatol; 2011 Mar; 38(3):229-35. PubMed ID: 21342224
[TBL] [Abstract][Full Text] [Related]
2. Occupational trichloroethylene hypersensitivity syndrome with human herpesvirus-6 and cytomegalovirus reactivation.
Watanabe H; Tohyama M; Kamijima M; Nakajima T; Yoshida T; Hashimoto K; Iijima M
Dermatology; 2010 Aug; 221(1):17-22. PubMed ID: 20407216
[TBL] [Abstract][Full Text] [Related]
3. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
Kamijima M; Wang H; Yamanoshita O; Ito Y; Xia L; Yanagiba Y; Chen C; Okamura A; Huang Z; Qiu X; Song X; Cai T; Liu L; Ge Y; Deng Y; Naito H; Yoshikawa T; Tohyama M; Li L; Huang H; Nakajima T
J Dermatol Sci; 2013 Dec; 72(3):218-24. PubMed ID: 23928230
[TBL] [Abstract][Full Text] [Related]
4. [Drug-induced hypersensitivity syndrome: DIHS].
Tohyama M; Hashimoto K
Arerugi; 2007 Nov; 56(11):1346-50. PubMed ID: 18059145
[No Abstract] [Full Text] [Related]
5. Increased serum anti-CYP2E1 IgG autoantibody levels may be involved in the pathogenesis of occupational trichloroethylene hypersensitivity syndrome: a case-control study.
Nakajima T; Wang H; Yuan Y; Ito Y; Naito H; Kawamoto Y; Takeda K; Sakai K; Zhao N; Li H; Qiu X; Xia L; Chen J; Wu Q; Li L; Huang H; Yanagiba Y; Yatsuya H; Kamijima M
Arch Toxicol; 2022 Oct; 96(10):2785-2797. PubMed ID: 35763063
[TBL] [Abstract][Full Text] [Related]
6. [Drug rash with eosinophilia and systemic symptoms (DRESS) attributed to the oral skin-care supplement Imedeen].
van Leeuwen JF; van der Hooft CS; Vos LE; Bekkenk MW; van Zuuren EJ; Stricker BH
Ned Tijdschr Geneeskd; 2005 Jun; 149(24):1353-6. PubMed ID: 16008041
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 6 reactivation in trichloroethylene-exposed workers suffering from generalized skin disorders accompanied by hepatic dysfunction.
Huang H; Kamijima M; Wang H; Li S; Yoshikawa T; Lai G; Huang Z; Liu H; Chen J; Takeuchi Y; Nakajima T; Li L
J Occup Health; 2006 Nov; 48(6):417-23. PubMed ID: 17179634
[TBL] [Abstract][Full Text] [Related]
8. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
Tas S; Simonart T
Acta Clin Belg; 1999 Aug; 54(4):197-200. PubMed ID: 10544509
[TBL] [Abstract][Full Text] [Related]
9. Trichloroethylene Hypersensitivity Syndrome: Should Be Considered When Diagnosing DRESS Syndrome.
Kang YJ; Lee J; Ahn J; Park S; Shin MY; Lee HW
J Korean Med Sci; 2018 Apr; 33(14):e106. PubMed ID: 29607632
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
[TBL] [Abstract][Full Text] [Related]
11. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
Kano Y; Shiohara T
Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
[TBL] [Abstract][Full Text] [Related]
12. HLA-B*1301 as a biomarker for genetic susceptibility to hypersensitivity dermatitis induced by trichloroethylene among workers in China.
Li H; Dai Y; Huang H; Li L; Leng S; Cheng J; Niu Y; Duan H; Liu Q; Zhang X; Huang X; Xie J; Feng Z; Wang J; He J; Zheng Y
Environ Health Perspect; 2007 Nov; 115(11):1553-6. PubMed ID: 18007983
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
14. DRESS syndrome: Part I. Clinical perspectives.
Husain Z; Reddy BY; Schwartz RA
J Am Acad Dermatol; 2013 May; 68(5):693.e1-14; quiz 706-8. PubMed ID: 23602182
[TBL] [Abstract][Full Text] [Related]
15. A case report of olanzapine-induced hypersensitivity syndrome.
Raz A; Bergman R; Eilam O; Yungerman T; Hayek T
Am J Med Sci; 2001 Feb; 321(2):156-8. PubMed ID: 11217818
[TBL] [Abstract][Full Text] [Related]
16. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
18. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Watanabe H
J Immunol Res; 2018; 2018():5163129. PubMed ID: 29744372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
